Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

Classic Block Design "Pseudo"-Resting-State fMRI Changes After a Neurorehabilitation Program in Patients with Multiple Sclerosis.

Pareto D, Sastre-Garriga J, Alonso J, Galán I, Arévalo MJ, Renom M, Montalban X, Rovira À.

J Neuroimaging. 2018 May;28(3):313-319. doi: 10.1111/jon.12500. Epub 2018 Feb 5.

PMID:
29400912
2.

A supervised framework with intensity subtraction and deformation field features for the detection of new T2-w lesions in multiple sclerosis.

Salem M, Cabezas M, Valverde S, Pareto D, Oliver A, Salvi J, Rovira À, Lladó X.

Neuroimage Clin. 2017 Nov 20;17:607-615. doi: 10.1016/j.nicl.2017.11.015. eCollection 2018.

3.

Evaluating the effect of multiple sclerosis lesions on automatic brain structure segmentation.

González-Villà S, Valverde S, Cabezas M, Pareto D, Vilanova JC, Ramió-Torrentà L, Rovira À, Oliver A, Lladó X.

Neuroimage Clin. 2017 May 8;15:228-238. doi: 10.1016/j.nicl.2017.05.003. eCollection 2017.

4.

Brain atrophy 15 years after CIS: Baseline and follow-up clinico-radiological correlations.

Vidal-Jordana A, Sastre-Garriga J, Pareto D, Tur C, Arrambide G, Otero-Romero S, Huerga E, Mitjana R, Auger C, Tintoré M, Rovira A, Montalban X.

Mult Scler. 2018 May;24(6):721-727. doi: 10.1177/1352458517707070. Epub 2017 Apr 26.

PMID:
28445084
5.

Improving automated multiple sclerosis lesion segmentation with a cascaded 3D convolutional neural network approach.

Valverde S, Cabezas M, Roura E, González-Villà S, Pareto D, Vilanova JC, Ramió-Torrentà L, Rovira À, Oliver A, Lladó X.

Neuroimage. 2017 Jul 15;155:159-168. doi: 10.1016/j.neuroimage.2017.04.034. Epub 2017 Apr 19.

PMID:
28435096
6.

Brain Atrophy in Multiple Sclerosis: Clinical Relevance and Technical Aspects.

Sastre-Garriga J, Pareto D, Rovira À.

Neuroimaging Clin N Am. 2017 May;27(2):289-300. doi: 10.1016/j.nic.2017.01.002. Epub 2017 Feb 20. Review.

PMID:
28391787
7.

Brain networks associated with cognitive and hedonic responses to a meal.

Pribic T, Kilpatrick L, Ciccantelli B, Malagelada C, Accarino A, Rovira A, Pareto D, Mayer E, Azpiroz F.

Neurogastroenterol Motil. 2017 Jun;29(6). doi: 10.1111/nmo.13031. Epub 2017 Jan 23.

PMID:
28116817
8.

Measurement of Cortical Thickness and Volume of Subcortical Structures in Multiple Sclerosis: Agreement between 2D Spin-Echo and 3D MPRAGE T1-Weighted Images.

Vidal-Jordana A, Pareto D, Sastre-Garriga J, Auger C, Ciampi E, Montalban X, Rovira A.

AJNR Am J Neuroradiol. 2017 Feb;38(2):250-256. doi: 10.3174/ajnr.A4999. Epub 2016 Nov 24.

9.

Automated tissue segmentation of MR brain images in the presence of white matter lesions.

Valverde S, Oliver A, Roura E, González-Villà S, Pareto D, Vilanova JC, Ramió-Torrentà L, Rovira À, Lladó X.

Med Image Anal. 2017 Jan;35:446-457. doi: 10.1016/j.media.2016.08.014. Epub 2016 Aug 30.

PMID:
27598104
10.

Neurofilament light chain level is a weak risk factor for the development of MS.

Arrambide G, Espejo C, Eixarch H, Villar LM, Alvarez-Cermeño JC, Picón C, Kuhle J, Disanto G, Kappos L, Sastre-Garriga J, Pareto D, Simon E, Comabella M, Río J, Nos C, Tur C, Castilló J, Vidal-Jordana A, Galán I, Arévalo MJ, Auger C, Rovira A, Montalban X, Tintore M.

Neurology. 2016 Sep 13;87(11):1076-84. doi: 10.1212/WNL.0000000000003085. Epub 2016 Aug 12. Erratum in: Neurology. 2016 Nov 8;87(19):2068.

11.

Comparison between gadolinium-enhanced 2D T1-weighted gradient-echo and spin-echo sequences in the detection of active multiple sclerosis lesions on 3.0T MRI.

Aymerich FX, Auger C, Alcaide-Leon P, Pareto D, Huerga E, Corral JF, Mitjana R, Sastre-Garriga J, Montalban X, Rovira A.

Eur Radiol. 2017 Apr;27(4):1361-1368. doi: 10.1007/s00330-016-4503-3. Epub 2016 Jul 25.

PMID:
27456965
12.

Grey matter atrophy is associated with disability increase in natalizumab-treated patients.

Ciampi E, Pareto D, Sastre-Garriga J, Vidal-Jordana A, Tur C, Río J, Tintoré M, Auger C, Rovira A, Montalban X.

Mult Scler. 2017 Apr;23(4):556-566. doi: 10.1177/1352458516656808. Epub 2016 Jul 11.

PMID:
27354019
13.

Improved Automatic Detection of New T2 Lesions in Multiple Sclerosis Using Deformation Fields.

Cabezas M, Corral JF, Oliver A, Díez Y, Tintoré M, Auger C, Montalban X, Lladó M, Pareto D, Rovira À.

AJNR Am J Neuroradiol. 2016 Jun 9. [Epub ahead of print]

PMID:
27282863
14.

Brain Volume Loss During the First Year of Interferon-Beta Treatment in Multiple Sclerosis: Baseline Inflammation and Regional Brain Volume Dynamics.

Vidal-Jordana A, Sastre-Garriga J, Pérez-Miralles F, Pareto D, Rio J, Auger C, Tintoré M, Rovira A, Montalban X.

J Neuroimaging. 2016 Sep;26(5):532-8. doi: 10.1111/jon.12337. Epub 2016 Mar 2.

PMID:
26935253
15.

Lesion filling effect in regional brain volume estimations: a study in multiple sclerosis patients with low lesion load.

Pareto D, Sastre-Garriga J, Aymerich FX, Auger C, Tintoré M, Montalban X, Rovira A.

Neuroradiology. 2016 May;58(5):467-74. doi: 10.1007/s00234-016-1654-5. Epub 2016 Feb 4.

PMID:
26847633
16.

Structural MRI correlates of cognitive impairment in patients with multiple sclerosis: A Multicenter Study.

Preziosa P, Rocca MA, Pagani E, Stromillo ML, Enzinger C, Gallo A, Hulst HE, Atzori M, Pareto D, Riccitelli GC, Copetti M, De Stefano N, Fazekas F, Bisecco A, Barkhof F, Yousry TA, Arévalo MJ, Filippi M; MAGNIMS Study Group.

Hum Brain Mapp. 2016 Apr;37(4):1627-44. doi: 10.1002/hbm.23125. Epub 2016 Feb 2.

PMID:
26833969
17.

Quantifying brain tissue volume in multiple sclerosis with automated lesion segmentation and filling.

Valverde S, Oliver A, Roura E, Pareto D, Vilanova JC, Ramió-Torrentà L, Sastre-Garriga J, Montalban X, Rovira À, Lladó X.

Neuroimage Clin. 2015 Oct 28;9:640-7. doi: 10.1016/j.nicl.2015.10.012. eCollection 2015.

18.

Juxtacortical Lesions and Cortical Thinning in Multiple Sclerosis.

Pareto D, Sastre-Garriga J, Auger C, Vives-Gilabert Y, Delgado J, Tintoré M, Montalban X, Rovira A.

AJNR Am J Neuroradiol. 2015 Dec;36(12):2270-6. doi: 10.3174/ajnr.A4485. Epub 2015 Oct 8.

19.

Apoptotic markers in cultured fibroblasts correlate with brain metabolites and regional brain volume in antipsychotic-naive first-episode schizophrenia and healthy controls.

Batalla A, Bargalló N, Gassó P, Molina O, Pareto D, Mas S, Roca JM, Bernardo M, Lafuente A, Parellada E.

Transl Psychiatry. 2015 Aug 25;5:e626. doi: 10.1038/tp.2015.122.

20.

A toolbox for multiple sclerosis lesion segmentation.

Roura E, Oliver A, Cabezas M, Valverde S, Pareto D, Vilanova JC, Ramió-Torrentà L, Rovira À, Lladó X.

Neuroradiology. 2015 Oct;57(10):1031-43. doi: 10.1007/s00234-015-1552-2. Epub 2015 Jul 31.

PMID:
26227167
21.

Predictive value of early brain atrophy on response in patients treated with interferon β.

Pérez-Miralles FC, Sastre-Garriga J, Vidal-Jordana A, Río J, Auger C, Pareto D, Tintoré M, Rovira A, Montalban X.

Neurol Neuroimmunol Neuroinflamm. 2015 Jul 2;2(4):e132. doi: 10.1212/NXI.0000000000000132. eCollection 2015 Aug.

22.

Aromatase imaging with [N-methyl-11C]vorozole PET in healthy men and women.

Biegon A, Alexoff DL, Kim SW, Logan J, Pareto D, Schlyer D, Wang GJ, Fowler JS.

J Nucl Med. 2015 Apr;56(4):580-5. doi: 10.2967/jnumed.114.150383. Epub 2015 Feb 19.

23.

Pixel-by-Pixel Comparison of Volume Transfer Constant and Estimates of Cerebral Blood Volume from Dynamic Contrast-Enhanced and Dynamic Susceptibility Contrast-Enhanced MR Imaging in High-Grade Gliomas.

Alcaide-Leon P, Pareto D, Martinez-Saez E, Auger C, Bharatha A, Rovira A.

AJNR Am J Neuroradiol. 2015 May;36(5):871-6. doi: 10.3174/ajnr.A4231. Epub 2015 Jan 29.

24.

Brain atrophy in natalizumab-treated patients: A 3-year follow-up.

Sastre-Garriga J, Tur C, Pareto D, Vidal-Jordana A, Auger C, Río J, Huerga E, Tintoré M, Rovira A, Montalban X.

Mult Scler. 2015 May;21(6):749-56. doi: 10.1177/1352458514556300. Epub 2014 Nov 12.

PMID:
25392330
25.

Functional correlates of cognitive dysfunction in multiple sclerosis: A multicenter fMRI Study.

Rocca MA, Valsasina P, Hulst HE, Abdel-Aziz K, Enzinger C, Gallo A, Pareto D, Riccitelli G, Muhlert N, Ciccarelli O, Barkhof F, Fazekas F, Tedeschi G, Arévalo MJ, Filippi M; MAGNIMS fMRI Study Group.

Hum Brain Mapp. 2014 Dec;35(12):5799-814. doi: 10.1002/hbm.22586. Epub 2014 Jul 18.

PMID:
25045065
26.

Kinetic analysis of [11C]vorozole binding in the human brain with positron emission tomography.

Logan J, Kim SW, Pareto D, Telang F, Wang GJ, Fowler JS, Biegon A.

Mol Imaging. 2014;13:1-12.

PMID:
24824855
27.

In vivo imaging of brain aromatase in female baboons: [11C]vorozole kinetics and effect of the menstrual cycle.

Pareto D, Biegon A, Alexoff D, Carter P, Shea C, Muench L, Xu Y, Fowler JS, Kim SW, Logan J.

Mol Imaging. 2013 Nov-Dec;12(8). doi: 10.2310/7290.2013.00068.

PMID:
24447618
28.

Optimization of [(11)C]raclopride positron emission tomographic rat studies: comparison of methods for image quantification.

Torrent E, Farré M, Abasolo I, Millan O, Llop J, Gispert JD, Ruiz A, Pareto D.

Mol Imaging. 2013 Jun;12(4):257-62.

PMID:
23651503
29.

Erythrocytes labeled with [(18) F]SFB as an alternative to radioactive CO for quantification of blood volume with PET.

Herance JR, Gispert JD, Abad S, Victor VM, Pareto D, Torrent È, Rojas S.

Contrast Media Mol Imaging. 2013 Jul-Aug;8(4):375-81. doi: 10.1002/cmmi.1533.

PMID:
23613441
30.

In vivo evaluation of amyloid deposition and brain glucose metabolism of 5XFAD mice using positron emission tomography.

Rojas S, Herance JR, Gispert JD, Abad S, Torrent E, Jiménez X, Pareto D, Perpiña U, Sarroca S, Rodríguez E, Ortega-Aznar A, Sanfeliu C.

Neurobiol Aging. 2013 Jul;34(7):1790-8. doi: 10.1016/j.neurobiolaging.2012.12.027. Epub 2013 Feb 10.

PMID:
23402900
31.

Positron emission tomographic imaging of the cannabinoid type 1 receptor system with [¹¹C]OMAR ([¹¹C]JHU75528): improvements in image quantification using wild-type and knockout mice.

Herance R, Rojas S, Abad S, Jiménez X, Gispert JD, Millán O, Martín-García E, Burokas A, Serra MÀ, Maldonado R, Pareto D.

Mol Imaging. 2011 Dec;10(6):481-7.

PMID:
22201539
32.

Improvement of cognitive flexibility and cingulate blood flow correlates after atypical antipsychotic treatment in drug-naive patients with first-episode schizophrenia.

Pardo BM, Garolera M, Ariza M, Pareto D, Salamero M, Valles V, Delgado L, Alberni J.

Psychiatry Res. 2011 Dec 30;194(3):205-211. doi: 10.1016/j.pscychresns.2011.06.001. Epub 2011 Oct 30.

PMID:
22044531
33.

[(11)C]-DASB microPET imaging in the aged rat: frontal and meso-thalamic increases in serotonin transporter binding.

Hoekzema E, Rojas S, Herance R, Pareto D, Abad S, Jiménez X, Figueiras FP, Popota F, Ruiz A, Flotats N, Fernández FJ, Rocha M, Rovira M, Víctor VM, Gispert JD.

Exp Gerontol. 2011 Dec;46(12):1020-5. doi: 10.1016/j.exger.2011.09.007. Epub 2011 Sep 29.

PMID:
21983171
34.

Biodistribution of amino-functionalized diamond nanoparticles. In vivo studies based on 18F radionuclide emission.

Rojas S, Gispert JD, Martín R, Abad S, Menchón C, Pareto D, Víctor VM, Alvaro M, García H, Herance JR.

ACS Nano. 2011 Jul 26;5(7):5552-9. doi: 10.1021/nn200986z. Epub 2011 Jun 10.

PMID:
21657210
35.

Positron emission tomography with 11C-flumazenil in the rat shows preservation of binding sites during the acute phase after 2 h-transient focal ischemia.

Rojas S, Martín A, Pareto D, Herance JR, Abad S, Ruíz A, Flotats N, Gispert JD, Llop J, Gómez-Vallejo V, Planas AM.

Neuroscience. 2011 May 19;182:208-16. doi: 10.1016/j.neuroscience.2011.03.013. Epub 2011 Mar 21.

PMID:
21402129
36.

In vivo molecular imaging of the GABA/benzodiazepine receptor complex in the aged rat brain.

Hoekzema E, Rojas S, Herance R, Pareto D, Abad S, Jiménez X, Figueiras FP, Popota F, Ruiz A, Flotats N, Fernández FJ, Rocha M, Rovira M, Víctor VM, Gispert JD.

Neurobiol Aging. 2012 Jul;33(7):1457-65. doi: 10.1016/j.neurobiolaging.2010.12.006. Epub 2011 Jan 26.

PMID:
21272959
37.

Consensus recommendations for MS cortical lesion scoring using double inversion recovery MRI.

Geurts JJ, Roosendaal SD, Calabrese M, Ciccarelli O, Agosta F, Chard DT, Gass A, Huerga E, Moraal B, Pareto D, Rocca MA, Wattjes MP, Yousry TA, Uitdehaag BM, Barkhof F; MAGNIMS Study Group.

Neurology. 2011 Feb 1;76(5):418-24. doi: 10.1212/WNL.0b013e31820a0cc4. Epub 2011 Jan 5.

PMID:
21209373
38.

The effects of aging on dopaminergic neurotransmission: a microPET study of [11C]-raclopride binding in the aged rodent brain.

Hoekzema E, Herance R, Rojas S, Pareto D, Abad S, Jiménez X, Figueiras FP, Popota F, Ruiz A, Torrent È, Fernández-Soriano FJ, Rocha M, Rovira M, Víctor VM, Gispert JD.

Neuroscience. 2010 Dec 29;171(4):1283-6. doi: 10.1016/j.neuroscience.2010.10.012. Epub 2010 Oct 14.

PMID:
20937365
39.

Unique distribution of aromatase in the human brain: in vivo studies with PET and [N-methyl-11C]vorozole.

Biegon A, Kim SW, Alexoff DL, Jayne M, Carter P, Hubbard B, King P, Logan J, Muench L, Pareto D, Schlyer D, Shea C, Telang F, Wang GJ, Xu Y, Fowler JS.

Synapse. 2010 Nov;64(11):801-7. doi: 10.1002/syn.20791.

40.

Simultaneous dual-tracer PET imaging of the rat brain and its application in the study of cerebral ischemia.

Figueiras FP, Jiménez X, Pareto D, Gómez V, Llop J, Herance R, Rojas S, Gispert JD.

Mol Imaging Biol. 2011 Jun;13(3):500-510. doi: 10.1007/s11307-010-0370-5.

PMID:
20652756
41.

Evaluation of hypoxic tissue dynamics with 18F-FMISO PET in a rat model of permanent cerebral ischemia.

Rojas S, Herance JR, Abad S, Jiménez X, Pareto D, Ruiz A, Torrent È, Figueiras FP, Popota F, Fernández-Soriano FJ, Planas AM, Gispert JD.

Mol Imaging Biol. 2011 Jun;13(3):558-564. doi: 10.1007/s11307-010-0371-4.

PMID:
20602176
42.

Depressed glucose consumption at reperfusion following brain ischemia does not correlate with mitochondrial dysfunction and development of infarction: an in vivo positron emission tomography study.

Martín A, Rojas S, Pareto D, Santalucia T, Millán O, Abasolo I, Gómez V, Llop J, Gispert JD, Falcon C, Bargalló N, Planas AM.

Curr Neurovasc Res. 2009 May;6(2):82-8.

43.

Synthesis and PET studies of [(11)C-cyano]letrozole (Femara), an aromatase inhibitor drug.

Kil KE, Biegon A, Ding YS, Fischer A, Ferrieri RA, Kim SW, Pareto D, Schueller MJ, Fowler JS.

Nucl Med Biol. 2009 Feb;36(2):215-23. doi: 10.1016/j.nucmedbio.2008.11.010.

44.

Fluordeoxyglucose-PET study in first-episode schizophrenic patients during the hallucinatory state, after remission and during linguistic-auditory activation.

Parellada E, Lomena F, Font M, Pareto D, Gutierrez F, Simo M, Fernández-Egea E, Pavia J, Ros D, Bernardo M.

Nucl Med Commun. 2008 Oct;29(10):894-900. doi: 10.1097/MNM.0b013e328302cd10.

PMID:
18769307
45.

Assessment of SPM in perfusion brain SPECT studies. A numerical simulation study using bootstrap resampling methods.

Pareto D, Aguiar P, Pavía J, Gispert JD, Cot A, Falcón C, Benabarre A, Lomeña F, Vieta E, Ros D.

IEEE Trans Biomed Eng. 2008 Jul;55(7):1849-53. doi: 10.1109/TBME.2008.919718.

PMID:
18595803
46.

Quantification of dopaminergic neurotransmission SPECT studies with 123I-labelled radioligands. A comparison between different imaging systems and data acquisition protocols using Monte Carlo simulation.

Crespo C, Gallego J, Cot A, Falcón C, Bullich S, Pareto D, Aguiar P, Sempau J, Lomeña F, Calviño F, Pavía J, Ros D.

Eur J Nucl Med Mol Imaging. 2008 Jul;35(7):1334-42. doi: 10.1007/s00259-007-0711-z. Epub 2008 Mar 12.

PMID:
18335217
47.

Effect of anatomical variability, reconstruction algorithms and scattered photons on the SPM output of brain PET studies.

Aguiar P, Pareto D, Gispert JD, Crespo C, Falcón C, Cot A, Lomeña F, Pavía J, Ros D.

Neuroimage. 2008 Feb 1;39(3):1121-8. Epub 2007 Oct 11.

PMID:
18042402
48.

Imaging brain inflammation with [(11)C]PK11195 by PET and induction of the peripheral-type benzodiazepine receptor after transient focal ischemia in rats.

Rojas S, Martín A, Arranz MJ, Pareto D, Purroy J, Verdaguer E, Llop J, Gómez V, Gispert JD, Millán O, Chamorro A, Planas AM.

J Cereb Blood Flow Metab. 2007 Dec;27(12):1975-86. Epub 2007 Apr 25.

PMID:
17457364
49.

Absolute quantification in dopaminergic neurotransmission SPECT using a Monte Carlo-based scatter correction and fully 3-dimensional reconstruction.

Cot A, Falcón C, Crespo C, Sempau J, Pareto D, Bullich S, Lomeña F, Calviño F, Pavía J, Ros D.

J Nucl Med. 2005 Sep;46(9):1497-504.

50.

Modeling and analysis of PET studies with norepinephrine transporter ligands: the search for a reference region.

Logan J, Ding YS, Lin KS, Pareto D, Fowler J, Biegon A.

Nucl Med Biol. 2005 Jul;32(5):531-42.

PMID:
15982584

Supplemental Content

Loading ...
Support Center